1,841
Views
1
CrossRef citations to date
0
Altmetric
Polycystic ovary syndrome

Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS)

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1104-1108 | Received 06 Jun 2022, Accepted 19 Dec 2022, Published online: 29 Dec 2022

References

  • Feng JG, Guo Y, Ma LA, et al. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in North China. J Cosmet Dermatol. 2018;17(3):511–517.
  • Chen J, Huang C, Zhang T, et al. The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2021;19(1):1–11.
  • Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15.
  • Li L, Yang D, Chen X, et al. Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet. 2007;97(2):129–134.
  • Lee AT, Zane LT. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol. 2007;8(4):201–219.
  • Kazemi H, Ramezani Tehrani F, Minooee S, et al. Women self-perception of excess hair growth, as a predictor of clinical hirsutism: a population-based study. J Endocrinol Invest. 2015;38(8):923–928.
  • Abusailik MA, Muhanna AM, Almuhisen AA, et al. Cutaneous manifestation of polycystic ovary syndrome. Dermatol Rep. 2021;13(2):8799.
  • Hong JS, Kwon HH, Park SY, et al. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in korean patients. J Eur Acad Dermatol Venereol. 2015;29(1):42–47.
  • Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89(2):453–462.
  • Thiboutot D, Gilliland K, Light J, et al. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol. 1999;135(9):1041–1045.
  • Slayden SM, Moran C, Sams WM, et al. Hyperandrogenemia in patients presenting with acne. Fertil Steril. 2001;75(5):889–892.
  • Falsetti L, Gambera A, Andrico S, et al. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecol Endocrinol. 2002;16(4):275–284.
  • Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341(7):491–497.
  • Mihailidis J, Dermesropian R, Taxel P, et al. Endocrine evaluation of hirsutism. Int J Womens Dermatol. 2017;3(1 Suppl):S6–S10.
  • Yildiz BO, Bolour S, Woods K, et al. Visually scoring hirsutism. Hum Reprod Update. 2010;16(1):51–64.
  • Özdemir S, Özdemir M, Görkemli H, et al. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand. 2010;89(2):199–204.
  • Cela E, Robertson C, Rush K, et al. Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol. 2003;149(5):439–442.
  • Fraser IS, Kovacs G. Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):813–823.
  • Schmidt TH, Shinkai K. Evidence-based approach to cutaneous hyperandrogenism in women. J Am Acad Dermatol. 2015;73(4):672–690.
  • Vijaya Gowri B, Chandravathi PL, Sindhu PS, et al. Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: a cross-sectional study clinical study. Indian J Dermatol. 2015;60(4):419.
  • Tamega ADA, Aranha AMP, Guiotoku MM, et al. Association between skin tags and insulin resistance. An Bras Dermatol. 2010;85(1):25–31.